Full Version | Search

The Irish Medicines Board - www.imb.ie

IMB Logo

Benlysta (belimumab) - Important Safety Information from GlaxoSmithKline as approved by the Irish Medicines Board

09 March 2012

Important Safety Information communicatin from GlaxoSmithKline on the association of Benlysta with hypersensitivity and infusion reactions.

Important Safety Information - Benlysta





Date Printed: 19 May 2013

© Irish Medicines Board 2013 | Developed by Engine Solutions www.engine.ie

Address: Kevin O'Malley House, Earlsfort Centre, Earlsfort Terrace, Dublin 2, Ireland.
Tel: 353-1-676 4971